417 related articles for article (PubMed ID: 27219686)
1. Diabetes and Cancer: a Review of Current Knowledge.
Wojciechowska J; Krajewski W; Bolanowski M; Kręcicki T; Zatoński T
Exp Clin Endocrinol Diabetes; 2016 May; 124(5):263-75. PubMed ID: 27219686
[TBL] [Abstract][Full Text] [Related]
2. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
[TBL] [Abstract][Full Text] [Related]
4. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
Lin CM; Huang HL; Chu FY; Fan HC; Chen HA; Chu DM; Wu LW; Wang CC; Chen WL; Lin SH; Ho SY
PLoS One; 2015; 10(5):e0125421. PubMed ID: 25978841
[TBL] [Abstract][Full Text] [Related]
5. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
Biadgo B; Abebe M
Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
[TBL] [Abstract][Full Text] [Related]
6. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
Ozawa H; Murai Y; Ozawa T
Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
[TBL] [Abstract][Full Text] [Related]
7. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.
Suh S; Kim KW
Diabetes Metab J; 2019 Dec; 43(6):733-743. PubMed ID: 31902143
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus: influences on cancer risk.
Szablewski L
Diabetes Metab Res Rev; 2014 Oct; 30(7):543-53. PubMed ID: 25044584
[TBL] [Abstract][Full Text] [Related]
9. Cancer risks from diabetes therapies: evaluating the evidence.
Li C; Kong D
Pharmacol Ther; 2014 Oct; 144(1):71-81. PubMed ID: 24844968
[TBL] [Abstract][Full Text] [Related]
10. Effect of metformin on the incidence of head and neck cancer in diabetics.
Yen YC; Lin C; Lin SW; Lin YS; Weng SF
Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563
[TBL] [Abstract][Full Text] [Related]
11. Challenges and perspectives in the treatment of diabetes associated breast cancer.
Samuel SM; Varghese E; Varghese S; Büsselberg D
Cancer Treat Rev; 2018 Nov; 70():98-111. PubMed ID: 30130687
[TBL] [Abstract][Full Text] [Related]
12. [New clinical data with metformin therapy in patients with diabetes mellitus].
Jermendy G
Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
[TBL] [Abstract][Full Text] [Related]
13. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
14. Cancer Biology and Prevention in Diabetes.
Srivastava SP; Goodwin JE
Cells; 2020 Jun; 9(6):. PubMed ID: 32498358
[TBL] [Abstract][Full Text] [Related]
15. Metformin: risk-benefit profile with a focus on cancer.
Provinciali N; Lazzeroni M; Cazzaniga M; Gorlero F; Dunn BK; DeCensi A
Expert Opin Drug Saf; 2015 Oct; 14(10):1573-85. PubMed ID: 26359221
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer.
Raguraman R; Srivastava A; Munshi A; Ramesh R
Adv Drug Deliv Rev; 2021 Nov; 178():113918. PubMed ID: 34375681
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
[TBL] [Abstract][Full Text] [Related]
19. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]